<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20432" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pediatric Type 2 Diabetes</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tillotson</surname>
            <given-names>Cara V.</given-names>
          </name>
          <aff>Virginia Tech - Carilion Children's</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bowden</surname>
            <given-names>Sasigarn A.</given-names>
          </name>
          <aff>The Ohio State University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shah</surname>
            <given-names>Manan</given-names>
          </name>
          <aff>Rutgers University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Boktor</surname>
            <given-names>Sameh W.</given-names>
          </name>
          <aff>Penn State College of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Cara Tillotson declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sasigarn Bowden declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Manan Shah declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sameh Boktor declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>11</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20432.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Type 2 diabetes mellitus is a metabolic disorder characterized by peripheral insulin resistance, leading to hyperglycemia. Once considered a predominantly adult disease, it has become a pressing concern in the field of pediatrics due to its rising incidence, mainly attributable to lifestyle factors and childhood obesity. This condition presents unique challenges in diagnosis, management, and long-term care compared to its type 1 counterpart, emphasizing the need for specialized knowledge and a patient-centered approach.&#x000a0;Early screening, recognition, and treatment of children with type 2 diabetes are crucial for preventing long-term complications. This activity&#x000a0;delves into the key aspects of pediatric type 2 diabetes, shedding light on its causes, diagnostic criteria, management strategies, and its broader impact on the health and well-being of affected children and adolescents.&#x000a0;It also highlights the role of interprofessional team members in collaborating to provide well-coordinated care and enhance outcomes for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify children at risk for type 2 diabetes mellitus.</p></list-item><list-item><p>Assess glycemic control, complications, and psychosocial needs in pediatric patients with type 2 diabetes mellitus.</p></list-item><list-item><p>Implement evidence-based interventions for managing pediatric type 2 diabetes mellitus, including lifestyle modifications, pharmacological therapies, and behavioral support.</p></list-item><list-item><p>Coordinate amongst&#x000a0;an interprofessional team to enhance care for&#x000a0;children and adolescents affected by type 2 diabetes mellitus.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20432&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20432">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20432.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Type 2 diabetes&#x000a0;mellitus (T2DM) is a metabolic disorder characterized by peripheral insulin resistance and a failure of beta cells to compensate, leading to hyperglycemia.<xref ref-type="bibr" rid="article-20432.r1">[1]</xref><xref ref-type="bibr" rid="article-20432.r2">[2]</xref><xref ref-type="bibr" rid="article-20432.r3">[3]</xref>&#x000a0;While once considered an adult pathology, it is increasingly prevalent in children.<xref ref-type="bibr" rid="article-20432.r4">[4]</xref> Risk factors for children are similar to those in adults: ethnicity, family history, obesity, and a sedentary lifestyle. However, presentation and management differ from adults with the disorder. Children with&#x000a0;diabetes of any kind are at an increased risk of many complications. Early recognition, screening, and treatment of children and adolescents with T2DM are important for preventing long-term complications from the disease.<xref ref-type="bibr" rid="article-20432.r5">[5]</xref></p>
      </sec>
      <sec id="article-20432.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Hyperglycemia results when there is a relative lack of insulin compared to glucose in the blood. In T2DM, insulin resistance first leads to increased insulin production by the beta cells of the pancreas.<xref ref-type="bibr" rid="article-20432.r5">[5]</xref>&#x000a0;Hyperglycemia results when the beta cells cannot produce enough insulin to maintain euglycemia. Hyperglycemia damages multiple organs, including kidneys, eyes, heart, and nerves. Further, hyperglycemia puts children at risk for other electrolyte disturbances.<xref ref-type="bibr" rid="article-20432.r6">[6]</xref>. Compared to adults, children with T2DM develop complications earlier and are often more challenging to manage.<xref ref-type="bibr" rid="article-20432.r7">[7]</xref></p>
        <p>There has been an increase in the diagnosis of T2DM secondary to the ever-increasing rates of obesity.<xref ref-type="bibr" rid="article-20432.r8">[8]</xref><xref ref-type="bibr" rid="article-20432.r9">[9]</xref> The general cause of adult and T2DM is similar, with some pathophysiological differences as mentioned below.<xref ref-type="bibr" rid="article-20432.r5">[5]</xref></p>
      </sec>
      <sec id="article-20432.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Type 1 diabetes mellitus (T1DM) remains the most prevalent form of diabetes in children. However,&#x000a0;T2DM is estimated to occur in&#x000a0;1 in&#x000a0;3 (20% to 33%) of new diagnoses of diabetes in children today. The rate of&#x000a0;T2DM in children continues to rise even as the obesity rates have plateaued in these age groups.<xref ref-type="bibr" rid="article-20432.r10">[10]</xref><xref ref-type="bibr" rid="article-20432.r11">[11]</xref><xref ref-type="bibr" rid="article-20432.r12">[12]</xref>&#x000a0;Girls are more affected than boys.<xref ref-type="bibr" rid="article-20432.r12">[12]</xref> Risk factors include high-risk ethnicity&#x000a0;(African American, Hispanic, Native American, Pacific Islanders, Asian Americans), a positive first-degree relative with the disorder, obesity, low birth weight, a mother with gestational diabetes, and female sex. It is more likely to be diagnosed during adolescence when insulin resistance is common due to multiple factors, including hormonal changes.&#x000a0;<xref ref-type="bibr" rid="article-20432.r10">[10]</xref><xref ref-type="bibr" rid="article-20432.r11">[11]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-20432.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Obesity leads to peripheral insulin resistance, which in turn leads to hyperglycemia. Insulin resistance occurs in multiple organs and tissues, eventually leading to beta-cell failure.<xref ref-type="bibr" rid="article-20432.r7">[7]</xref> Generally speaking, insulin resistance can be present for a significant period of time before the diagnosis of T2DM.<xref ref-type="bibr" rid="article-20432.r7">[7]</xref> It is important to note that visceral obesity, rather than BMI, may be a better predictor for the complications of insulin resistance, including T2DM and hypertension.<xref ref-type="bibr" rid="article-20432.r7">[7]</xref> Independent of obesity, certain ethnicities have higher risks of insulin resistance and beta cell dysfunction. In addition, hormonal changes at puberty result in temporary insulin resistance, leading to hyperglycemia and the risk of developing T2DM.<xref ref-type="bibr" rid="article-20432.r13">[13]</xref> Hyperglycemia leads to an osmotic diuresis (polyuria), which increases thirst (polydipsia). This diuresis causes moderate to severe dehydration.</p>
        <p>Prolonged hyperglycemia can produce&#x000a0;2 distinct emergent states in&#x000a0;T2DM in children:&#x000a0;<xref ref-type="bibr" rid="article-20432.r14">[14]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Diabetic Ketoacidosis (DKA)</bold>: much more common in children with&#x000a0;T2DM than adults. Lack of insulin inhibits the body's ability to use glucose for energy and reverts to breaking down fat for energy. This leads to ketosis, acidosis, and electrolyte abnormalities and may lead to coma and death.&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Hyperglycemic Hyperosmolar State (HHS):</bold> characterized by hypertonicity, extreme hyperglycemia (&#x0003e;600 mg/dl), and severe dehydration. The profound hyperglycemia results in continued osmotic diuresis and intravascular depletion.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20432.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Children with&#x000a0;T2DM most often present during asymptomatic screening.</p>
        <p>Children may have the typical symptoms of polyuria, polydipsia, polyphagia, and weight loss. Children with&#x000a0;T2DM are more likely than adults with the disorder to present in DKA (5% to 13%), especially if they are of ethnic minority descent. Adolescents with&#x000a0;T2DM may also present in HHS.&#x000a0;</p>
        <p>Physical examination findings&#x000a0;may include acanthosis nigricans (a dark, velvety rash on the axillae and/or neck). The American Diabetes Association (ADA) recommends screening children at 10 years old or at the start of puberty in children who are obese (&#x0003e;95th percentile BMI for age) or are overweight (BMI &#x0003e;85th percentile for age or&#x000a0;&#x0003e;120% ideal body weight) and have&#x000a0;2 risk factors. These factors&#x000a0;include a positive family history, high-risk ethnicity, signs of insulin resistance (polycystic ovary syndrome (PCOS), acanthosis nigricans,&#x000a0; diabetic symptoms), or a history of maternal gestational&#x000a0;diabetes&#x000a0;mellitus.</p>
      </sec>
      <sec id="article-20432.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The American Diabetes Association (ADA) recommends screening for&#x000a0;T2DM &#x000a0;every&#x000a0;3 years starting at age 10 years (or at the onset of puberty) for patients who are:&#x000a0;<xref ref-type="bibr" rid="article-20432.r15">[15]</xref><xref ref-type="bibr" rid="article-20432.r16">[16]</xref><xref ref-type="bibr" rid="article-20432.r17">[17]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Obese (BMI&#x000a0;&#x02265;95th percentile for age)&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Overweight (BMI &#x02265; 85th percentile for age) and have at least&#x000a0;2 risk factors (positive family history, high-risk race or ethnicity, signs of insulin resistance, maternal history of gestational diabetes).&#x000a0;</p>
          </list-item>
        </list>
        <p>
<bold>Diagnostic Criteria:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Random plasma blood glucose&#x000a0;&#x02265;200 mg/dl with symptoms of polyuria, polydipsia, or weight loss</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Fasting blood glucose &#x02265;126 mg/dl in an asymptomatic patient.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Oral glucose tolerance test (GTT) with blood sugar&#x000a0;&#x02265; 200 mg/dl at&#x000a0;2 hours post-ingestion.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hemoglobin A1c &#x0003e;6.5%</p>
          </list-item>
        </list>
        <p>If the diagnosis between&#x000a0;T1DM and T2DM is unclear, helpful labs include fasting insulin or C-peptide (both usually high or normal in T2DM, low in T1DM) and autoantibodies for T1DM.</p>
      </sec>
      <sec id="article-20432.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The American Academy of Pediatrics (AAP) recommends lifestyle modifications and metformin as the first-line therapy. Lifestyle changes include moderate to vigorous exercise for 60 minutes daily, limiting screen time to less than&#x000a0;2 hours per day, and a dietary referral.<xref ref-type="bibr" rid="article-20432.r18">[18]</xref><xref ref-type="bibr" rid="article-20432.r19">[19]</xref><xref ref-type="bibr" rid="article-20432.r20">[20]</xref><xref ref-type="bibr" rid="article-20432.r21">[21]</xref></p>
        <p>Metformin and/or insulin should be started at diagnosis. Metformin is first-line and available as a liquid. It can be started at 500 mg/day and increased by 500 mg every 1 to&#x000a0;2 weeks to a maximum of 2000 mg twice&#x000a0;per day. The gradual increase of the medication and taking it with food helps to prevent adverse gastrointestinal effects.</p>
        <p>Insulin should be started for patients who are ketotic or in DKA, have a random blood glucose &#x0003e;250 mg/dl, a hemoglobin A1c &#x0003e;8.5%, or in whom the diagnosis of&#x000a0;T1DM versus&#x000a0;T2DM is unclear.&#x000a0;A basal/bolus regimen like in T1DM may be used, but typically, T2DM patients require higher doses (2&#x000a0;units/kg/day to 3 units/kg/day). Insulin should be initiated and managed by pediatric endocrinologists. Insulin takers have a risk of hypoglycemia; therefore, frequent monitoring is required.<xref ref-type="bibr" rid="article-20432.r13">[13]</xref></p>
        <p>Home glucose monitoring is recommended for those who take insulin, have not met glucose control goals, are changing medications, or are sick.</p>
        <p>Hemoglobin A1c test goals vary by association. The ADA and AAP list an A1c test goal of &#x0003c;7%, while the American Association of Clinical Endocrinologists places the goal at &#x0003c;6.5%.</p>
      </sec>
      <sec id="article-20432.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis for pediatric T2DM includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Atypical diabetes mellitus (ADM)</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Maturity-onset diabetes of the young (MODY)</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Diabetes secondary to mutations in DNA</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Diseases of the exocrine pancreas</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Drug or chemical-induced diabetes</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Diabetic ketoacidosis (DKA)</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Endocrinopathies</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Genetic defects of beta cells&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Genetic defects in insulin action&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Type 1 diabetes mellitus (T1DM)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20432.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>There have been no long-term prognosis studies for pediatric T2DM.&#x000a0;The prognosis&#x000a0;is of great concern in the medical community, primarily due to its potential for long-term complications. Many children and adolescents can achieve good glycemic control and lead healthy lives with proper treatment, lifestyle modifications, and regular monitoring.&#x000a0;While the condition is manageable, it can lead to significant health challenges if not well-controlled. The risk of complications, including cardiovascular disease, kidney problems, and retinopathy, remains a real and persistent threat. The long-term prognosis is intricately tied to the child's ability to adhere to treatment plans, maintain a healthy lifestyle, and receive consistent medical care. Early diagnosis, comprehensive education, and robust support systems are crucial for improving the prognosis and minimizing the risk of severe complications in pediatric patients with T2DM.</p>
      </sec>
      <sec id="article-20432.s11" sec-type="Complications">
        <title>Complications</title>
        <p>There are significant long-term complications for children with T2DM, and they often occur earlier in the disease course than their adult counterparts.<xref ref-type="bibr" rid="article-20432.r7">[7]</xref>&#x000a0;Evidence shows that these patients begin to experience renal and neurological complications within 10 years of the disease, including the need for dialysis, amputation, and blindness.<xref ref-type="bibr" rid="article-20432.r22">[22]</xref>&#x000a0;Compared with children who do not have diabetes, those with diabetes increase their risk of dialysis almost 40-fold.<xref ref-type="bibr" rid="article-20432.r23">[23]</xref>&#x000a0;</p>
        <p>For adult patients with T2DM, there is a significant reduction in life expectancy compared to patients without T2DM.<xref ref-type="bibr" rid="article-20432.r24">[24]</xref>&#x000a0;Given the recent increase in pediatric T2DM amongst the general population, no data on life expectancy associated with pediatric T2DM exists.</p>
        <p>There is also data to suggest that having adult T2DM puts patients at higher risk of further complications such as cancers and other non-vascular causes<xref ref-type="bibr" rid="article-20432.r25">[25]</xref>.&#x000a0;In pediatric patients, approximately a quarter of children with T2DM will have hypertension, and slightly over&#x000a0;20% have albuminuria.<xref ref-type="bibr" rid="article-20432.r26">[26]</xref></p>
      </sec>
      <sec id="article-20432.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>The specialties often consulted for patients with pediatric T2DM include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pediatric Endocrinology&#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0; &#x000a0;&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Pediatric Opthalmology</p>
          </list-item>
          <list-item>
            <p>Pediatric Nephrology</p>
          </list-item>
          <list-item>
            <p>Registered Dietician</p>
          </list-item>
          <list-item>
            <p>Child and Adolescent Psychiatry</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-20432.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>There is a sizeable familial component to pediatric T2DM.<xref ref-type="bibr" rid="article-20432.r27">[27]</xref>&#x000a0;Preventing&#x000a0;T2DM&#x000a0;in children primarily involves addressing modifiable risk factors, such as obesity and a sedentary lifestyle. Encouraging healthy eating habits, regular physical activity, and weight management can significantly reduce the risk of developing the condition.<xref ref-type="bibr" rid="article-20432.r28">[28]</xref> Public health campaigns, school programs, and community initiatives promoting a healthy lifestyle are essential for deterrence.</p>
        <p>Educating pediatric patients and their caregivers about&#x000a0;T2DM is paramount. They should understand the importance of dietary choices, portion control, and the significance of regular exercise in managing the condition. Patients need to learn self-monitoring techniques, such as blood glucose testing and the proper administration of medications if prescribed. Patient education should be ongoing and tailored to the child's age and comprehension level.</p>
        <p>Incorporating both deterrence strategies and comprehensive patient education into clinical practice can lead to better outcomes and a reduced incidence of pediatric T2DM. By empowering children and their families with the knowledge and the tools to make healthy choices, the&#x000a0;medical community can help mitigate the impact of this growing health concern.</p>
      </sec>
      <sec id="article-20432.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Complications of&#x000a0;T2DM in children are similar to those of adults. Complications tend to occur after a patient has had the disease for many years. Those who are diagnosed in childhood have the disease for longer periods of time. Therefore, strict control and management of blood glucose are crucial to help prevent these complications. All people with diabetes should have regular dilated eye exams (to examine for diabetic retinopathy), urine microalbumin screening at appropriate intervals (to evaluate for renal involvement), hyperlipidemia screens/treatment, hypertension screening/treatment, and regular monitoring.<xref ref-type="bibr" rid="article-20432.r29">[29]</xref></p>
      </sec>
      <sec id="article-20432.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>T2DM&#x000a0;in children is best managed by an interprofessional team that includes a pediatrician or primary care provider, endocrinologist, pharmacist, diabetic nurse, dietician, and relevant specialists.&#x000a0;It is vital to ensure that these children are also evaluated by&#x000a0;an ophthalmologist, nephrologist, cardiologist, and dental surgeon.&#x000a0;</p>
        <p>Physicians should have proficiency in diagnosis, medication management, and complication prevention. Nurses play a crucial role in patient education and ongoing monitoring. Pharmacists ensure appropriate medication selection and dosing. Open, transparent communication among team members is essential to meet the patient's needs. Regular case discussions and updates are crucial for optimal care.&#x000a0;Efficient care coordination is vital, including aligning appointments and services to provide holistic, patient-centered care.</p>
        <p>A cohesive strategy should encompass regular patient education, dietary guidance, medication management, and exercise plans. Monitoring blood glucose levels and identifying early signs of complications is pivotal. An&#x000a0;interprofessional team approach ensures that the patient receives well-rounded, evidence-based care and significantly improves outcomes in managing pediatric T2DM.</p>
      </sec>
      <sec id="article-20432.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20432&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20432">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/diabetes/pediatric-type-2-diabetes/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=20432">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20432/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20432">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20432.s17">
        <title>References</title>
        <ref id="article-20432.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Shankar</surname>
                <given-names>RR</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of type 1 and type 2 diabetes among US pediatric population in the MarketScan Multi-State Database, 2002 to 2016.</article-title>
            <source>Pediatr Diabetes</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>20</volume>
            <issue>5</issue>
            <fpage>523</fpage>
            <page-range>523-529</page-range>
            <pub-id pub-id-type="pmid">30861241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winhusen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Theobald</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kaelber</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.</article-title>
            <source>Addiction</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>114</volume>
            <issue>8</issue>
            <fpage>1462</fpage>
            <page-range>1462-1470</page-range>
            <pub-id pub-id-type="pmid">30851217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crawford</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sims</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Youssef</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nadarajah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rivas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Banfield</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thabane</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Samaan</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Traditional knowledge-based lifestyle interventions in the prevention of obesity and type 2 diabetes in Indigenous children in Canada: a systematic review protocol.</article-title>
            <source>Syst Rev</source>
            <year>2019</year>
            <month>Mar</month>
            <day>06</day>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>69</fpage>
            <pub-id pub-id-type="pmid">30841917</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hannon</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Arslanian</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>1353</volume>
            <fpage>113</fpage>
            <page-range>113-37</page-range>
            <pub-id pub-id-type="pmid">26448515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Zeitler</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pena</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Wicklow</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Arslanian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dabadghao</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pinhas-Hamiel</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Urakami</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>ISPAD Clinical Practice Consensus Guidelines 2022: Type 2 diabetes in children and adolescents.</article-title>
            <source>Pediatr Diabetes</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>23</volume>
            <issue>7</issue>
            <fpage>872</fpage>
            <page-range>872-902</page-range>
            <pub-id pub-id-type="pmid">36161685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hern&#x000e1;ndez-Montoya</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Soriano-Flores</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Esparza-Aguilar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Benjet</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Llanes-D&#x000ed;az</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Variation in incidence of type 2 diabetes mellitus: time series of Mexican adolescents.</article-title>
            <source>Ann Epidemiol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>30</volume>
            <fpage>15</fpage>
            <page-range>15-21</page-range>
            <pub-id pub-id-type="pmid">30528324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Valaiyapathi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gower</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ashraf</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology of Type 2 Diabetes in Children and Adolescents.</article-title>
            <source>Curr Diabetes Rev</source>
            <year>2020</year>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>220</fpage>
            <page-range>220-229</page-range>
            <pub-id pub-id-type="pmid">29879890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dabelea</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mayer-Davis</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Saydah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Imperatore</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Linder</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Divers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Badaru</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Talton</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Crume</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Liese</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Merchant</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Lawrence</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Reynolds</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dolan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Hamman</surname>
                <given-names>RF</given-names>
              </name>
              <collab>SEARCH for Diabetes in Youth Study</collab>
            </person-group>
            <article-title>Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.</article-title>
            <source>JAMA</source>
            <year>2014</year>
            <month>May</month>
            <day>07</day>
            <volume>311</volume>
            <issue>17</issue>
            <fpage>1778</fpage>
            <page-range>1778-86</page-range>
            <pub-id pub-id-type="pmid">24794371</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Copeland</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Zeitler</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Geffner</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guandalini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hirst</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Linder</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Marcovina</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>McGuigan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pyle</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tamborlane</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Willi</surname>
                <given-names>S</given-names>
              </name>
              <collab>TODAY Study Group</collab>
            </person-group>
            <article-title>Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2011</year>
            <month>Jan</month>
            <volume>96</volume>
            <issue>1</issue>
            <fpage>159</fpage>
            <page-range>159-67</page-range>
            <pub-id pub-id-type="pmid">20962021</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jensen</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Dabelea</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Type 2 Diabetes in Youth: New Lessons from the SEARCH Study.</article-title>
            <source>Curr Diab Rep</source>
            <year>2018</year>
            <month>May</month>
            <day>08</day>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>36</fpage>
            <pub-id pub-id-type="pmid">29737424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pelham</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Hanks</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Aslibekyan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dowla</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ashraf</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Higher hemoglobin A1C and atherogenic lipoprotein profiles in children and adolescents with type 2 diabetes mellitus.</article-title>
            <source>J Clin Transl Endocrinol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>15</volume>
            <fpage>30</fpage>
            <page-range>30-34</page-range>
            <pub-id pub-id-type="pmid">30547005</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayer-Davis</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Lawrence</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Dabelea</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Divers</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Isom</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dolan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Imperatore</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Linder</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Marcovina</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pettitt</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Pihoker</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Saydah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wagenknecht</surname>
                <given-names>L</given-names>
              </name>
              <collab>SEARCH for Diabetes in Youth Study</collab>
            </person-group>
            <article-title>Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012.</article-title>
            <source>N Engl J Med</source>
            <year>2017</year>
            <month>Apr</month>
            <day>13</day>
            <volume>376</volume>
            <issue>15</issue>
            <fpage>1419</fpage>
            <page-range>1419-1429</page-range>
            <pub-id pub-id-type="pmid">28402773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flint</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arslanian</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Treatment of type 2 diabetes in youth.</article-title>
            <source>Diabetes Care</source>
            <year>2011</year>
            <month>May</month>
            <volume>34 Suppl 2</volume>
            <issue>Suppl 2</issue>
            <fpage>S177</fpage>
            <page-range>S177-83</page-range>
            <pub-id pub-id-type="pmid">21525452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caprio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pierpont</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kursawe</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The "adipose tissue expandability" hypothesis: a potential mechanism for insulin resistance in obese youth.</article-title>
            <source>Horm Mol Biol Clin Investig</source>
            <year>2018</year>
            <month>Mar</month>
            <day>29</day>
            <volume>33</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29596053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Fermin</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Filipp</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Gurka</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>DeBoer</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Examining trends in prediabetes and its relationship with the metabolic syndrome in US adolescents, 1999-2014.</article-title>
            <source>Acta Diabetol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>373</fpage>
            <page-range>373-381</page-range>
            <pub-id pub-id-type="pmid">28070750</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hagman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Danielsson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Brandt</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ekbom</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Association between impaired fasting glycaemia in pediatric obesity and type 2 diabetes in young adulthood.</article-title>
            <source>Nutr Diabetes</source>
            <year>2016</year>
            <month>Aug</month>
            <day>22</day>
            <volume>6</volume>
            <issue>8</issue>
            <fpage>e227</fpage>
            <pub-id pub-id-type="pmid">27548712</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oester</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Kloppenborg</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Johannesen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Type 2 diabetes mellitus in Danish children and adolescents in 2014.</article-title>
            <source>Pediatr Diabetes</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>368</fpage>
            <page-range>368-73</page-range>
            <pub-id pub-id-type="pmid">26111830</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhatt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nahari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Kearsley</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Falzone</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jeyakumar</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zukowski</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Banfield</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Thabane</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Samaan</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>The quality of clinical practice guidelines for management of pediatric type 2 diabetes mellitus: a systematic review using the AGREE II instrument.</article-title>
            <source>Syst Rev</source>
            <year>2018</year>
            <month>Nov</month>
            <day>15</day>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>193</fpage>
            <pub-id pub-id-type="pmid">30442196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Albert P&#x000e9;rez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mateu Olivares</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mart&#x000ed;nez-Espinosa</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Molina Vila</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Reig Garc&#x000ed;a-Galbis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>New Insights about How to Make an Intervention in Children and Adolescents with Metabolic Syndrome: Diet, Exercise vs. Changes in Body Composition. A Systematic Review of RCT.</article-title>
            <source>Nutrients</source>
            <year>2018</year>
            <month>Jul</month>
            <day>06</day>
            <volume>10</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">29986479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cha</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Braxter</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Umpierrez</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Faulkner</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Dietary Behaviors and Glucose Metabolism in Young Adults at Risk for Type 2 Diabetes.</article-title>
            <source>Diabetes Educ</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>158</fpage>
            <page-range>158-167</page-range>
            <pub-id pub-id-type="pmid">29495910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vaughan</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Cardenas</surname>
                <given-names>VJ</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Foreyt</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Integrating CHWs as Part of the Team Leading Diabetes Group Visits: A Randomized Controlled Feasibility Study.</article-title>
            <source>Diabetes Educ</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>43</volume>
            <issue>6</issue>
            <fpage>589</fpage>
            <page-range>589-599</page-range>
            <pub-id pub-id-type="pmid">29047326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dart</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Martens</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Rigatto</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brownell</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Dean</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Sellers</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Earlier onset of complications in youth with type 2 diabetes.</article-title>
            <source>Diabetes Care</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>436</fpage>
            <page-range>436-43</page-range>
            <pub-id pub-id-type="pmid">24130346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dart</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Sellers</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Martens</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Rigatto</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brownell</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Dean</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>High burden of kidney disease in youth-onset type 2 diabetes.</article-title>
            <source>Diabetes Care</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>6</issue>
            <fpage>1265</fpage>
            <page-range>1265-71</page-range>
            <pub-id pub-id-type="pmid">22432116</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kianmehr</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pavkov</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Bullard</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Gregg</surname>
                <given-names>EW</given-names>
              </name>
              <name>
                <surname>Ospina</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Potential Gains in Life Expectancy Associated With Achieving Treatment Goals in US Adults With Type 2 Diabetes.</article-title>
            <source>JAMA Netw Open</source>
            <year>2022</year>
            <month>Apr</month>
            <day>01</day>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>e227705</fpage>
            <pub-id pub-id-type="pmid">35435970</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rao Kondapally Seshasai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaptoge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Di Angelantonio</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sarwar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Whincup</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Mukamal</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Gillum</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Holme</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Nj&#x000f8;lstad</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Fletcher</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lewington</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gudnason</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Sattar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Selvin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Danesh</surname>
                <given-names>J</given-names>
              </name>
              <collab>Emerging Risk Factors Collaboration</collab>
            </person-group>
            <article-title>Diabetes mellitus, fasting glucose, and risk of cause-specific death.</article-title>
            <source>N Engl J Med</source>
            <year>2011</year>
            <month>Mar</month>
            <day>03</day>
            <volume>364</volume>
            <issue>9</issue>
            <fpage>829</fpage>
            <page-range>829-841</page-range>
            <pub-id pub-id-type="pmid">21366474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cioana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nadarajah</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Qiu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SSJ</given-names>
              </name>
              <name>
                <surname>Rivas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Banfield</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chanchlani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wicklow</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Alfaraidi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Alotaibi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thabane</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Samaan</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of Hypertension and Albuminuria in Pediatric Type 2 Diabetes: A Systematic Review and Meta-analysis.</article-title>
            <source>JAMA Netw Open</source>
            <year>2021</year>
            <month>Apr</month>
            <day>01</day>
            <volume>4</volume>
            <issue>4</issue>
            <fpage>e216069</fpage>
            <pub-id pub-id-type="pmid">33929524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Willemsen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bowden</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dalg&#x000e5;rd</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Kaprio</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lyle</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Magnusson</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Mather</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ordo&#x00148;ana</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Perez-Riquelme</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Pietil&#x000e4;inen</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Sachdev</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Boomsma</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Spector</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The Concordance and Heritability of Type 2 Diabetes in 34,166 Twin Pairs From International Twin Registers: The Discordant Twin (DISCOTWIN) Consortium.</article-title>
            <source>Twin Res Hum Genet</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>18</volume>
            <issue>6</issue>
            <fpage>762</fpage>
            <page-range>762-71</page-range>
            <pub-id pub-id-type="pmid">26678054</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rush</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Simmons</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Physical activity in children: prevention of obesity and type 2 diabetes.</article-title>
            <source>Med Sport Sci</source>
            <year>2014</year>
            <volume>60</volume>
            <fpage>113</fpage>
            <page-range>113-21</page-range>
            <pub-id pub-id-type="pmid">25226806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20432.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zurita-Cruz</surname>
                <given-names>JN</given-names>
              </name>
              <name>
                <surname>Manuel-Apolinar</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Arellano-Flores</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Gutierrez-Gonzalez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Najera-Ahumada</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Cisneros-Gonz&#x000e1;lez</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Health and quality of life outcomes impairment of quality of life in type 2 diabetes mellitus: a cross-sectional study.</article-title>
            <source>Health Qual Life Outcomes</source>
            <year>2018</year>
            <month>May</month>
            <day>15</day>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>94</fpage>
            <pub-id pub-id-type="pmid">29764429</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
